IP Library Granted Patent US 12,286,666
Granted Patent B2
US 12,286,666 · App. 18/443,079 · Granted Apr 29, 2025

Methods for in situ transcriptomics and proteomics

Inventors: Eli N. Glezer (Del Mar, CA); Hu Cang (San Diego, CA); Zhenmin Hong (San Diego, CA)
Assignee: SINGULAR GENOMICS SYSTEMS, INC.
C12Q1/6841C12Q1/6804G01N33/5308G01N33/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,286,666
App. No.
18/443,079
Granted
Apr 29, 2025
Kind
B2
Abstract

Disclosed herein, inter alia, are compositions and methods of use thereof for interrogating a cell.

Claims (30)

1. A method of sequencing, said method comprising

contacting a cell or tissue comprising a nucleic acid molecule with a polynucleotide probe comprising a first target hybridization sequence and a second target hybridization sequence;

hybridizing the first target hybridization sequence to the nucleic acid molecule and hybridizing the second target hybridization sequence to the nucleic acid molecule;

ligating the first target hybridization sequence to the second target hybridization sequence to form a circular polynucleotide;

amplifying the circular polynucleotide to form an amplification product; and

hybridizing a first sequencing primer to the amplification product, and sequencing the first target hybridization sequence or the second target hybridization sequence.

2. The method of claim 1 , wherein said nucleic acid molecule is in the cell.

3. The method of claim 1 , wherein the first target hybridization sequence is greater in length than the second target hybridization sequence.

4. The method of claim 1 , wherein sequencing comprises extending the first sequencing primer by incorporating a labeled nucleotide, or labeled nucleotide analogue and detecting the label for each incorporated nucleotide or nucleotide analogue.

5. The method of claim 4 , wherein the labeled nucleotide or labeled nucleotide analogue further comprises a reversible terminator moiety.

6. The method of claim 1 , wherein the cell or tissue is permeabilized and immobilized to a solid support.

7. The method of claim 1 , wherein the method does not comprise lysing the cell.

8. The method of claim 1 , further comprising detecting the nucleic acid molecule by identifying the first target hybridization sequence, the second target hybridization sequence, or both the first target hybridization sequence and the second target hybridization sequence.

9. The method of claim 1 , wherein the polynucleotide probe further comprises a barcode sequence.

10. The method of claim 9 , further comprising sequencing the barcode sequence, and detecting the nucleic acid molecule by identifying the first target hybridization sequence and barcode sequence, or the second target hybridization sequence and the barcode sequence.

11. The method of claim 1 , wherein the polynucleotide probe comprises one or more locked nucleic acid (LNA) nucleotides.

12. The method of claim 1 , further comprising contacting the cell or tissue with a second polynucleotide probe comprising a third target hybridization sequence and a fourth target hybridization sequence; hybridizing the third target hybridization sequence to a different nucleic acid molecule and hybridizing the fourth target hybridization sequence to a different nucleic acid molecule; and sequencing the third target hybridization sequence or the fourth target hybridization sequence.

13. The method of claim 1 , wherein the nucleic acid molecule comprises a gene sequence.

14. A method of detecting a gene sequence, said method comprising:

contacting a cell or tissue comprising a first nucleic acid molecule comprising the gene sequence with a first polynucleotide probe comprising a first target hybridization sequence and a second target hybridization sequence; hybridizing the first target hybridization sequence to the first nucleic acid molecule and hybridizing the second target hybridization sequence to the first nucleic acid molecule; ligating the first target hybridization sequence to the second target hybridization sequence to form a first circular polynucleotide;

contacting the cell or tissue comprising a second nucleic acid molecule comprising the gene sequence with a second polynucleotide probe comprising a third target hybridization sequence and a fourth target hybridization sequence; hybridizing the third target hybridization sequence to the second nucleic acid molecule and hybridizing the fourth target hybridization sequence to the second nucleic acid molecule; ligating the third target hybridization sequence to the fourth target hybridization sequence to form a second circular polynucleotide;

amplifying the first circular polynucleotide to form a first amplification product and amplifying the second circular polynucleotide to form a second amplification product;

hybridizing a first sequencing primer to the first amplification product, and sequencing the first target hybridization sequence or the second target hybridization sequence; and

hybridizing a second sequencing primer to the second amplification product, and sequencing the third target hybridization sequence or the fourth target hybridization sequence.

15. The method of claim 1 , wherein amplifying the circular polynucleotide comprises hybridizing an amplification primer to the circular polynucleotide and extending the amplification primer with a strand-displacing polymerase.

16. The method of claim 1 , wherein the nucleic acid molecule is an RNA molecule.

17. The method of claim 1 , wherein the nucleic acid molecule is a DNA molecule.

18. The method of claim 12 , prior to hybridizing the second sequencing primer, further comprising incorporating with a polymerase an irreversibly terminated nucleotide into the first sequencing primer.

19. The method of claim 1 , wherein the first target hybridization sequence and the second target hybridization sequence are independently about 15 to 20 nucleotides.

20. The method of claim 1 , wherein the first target hybridization sequence and the second target hybridization sequence consist of deoxyribonucleotide residues.

Assignments (2)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2024
From: GLEZER, ELI N.; CANG, HU; HONG, ZHENMIN
To: SINGULAR GENOMICS SYSTEMS, INC.
Reel/Frame 067469/0281 →
Continuity (10)
Continuation 18469871 · Sep 19, 2023
Continuation 17938329 · Oct 5, 2022
Continuation 17816841 · Aug 2, 2022
Continuation 17840473 · Jun 14, 2022
Continuation 17840469 · Jun 14, 2022
Continuation 17396575 · Aug 6, 2021
Provisional Application 63209886 · Jun 11, 2021
Provisional Application 63140700 · Jan 22, 2021
Provisional Application 63062054 · Aug 6, 2020
Related Publication 20240182956A1 · Jun 6, 2024
References Cited (261)
US 4792520A · Stambrook et al. · 1988 [cited by applicant]
US 6218122B1 · Friend et al. · 2001 [cited by applicant]
US 6365367B1 · Friedman et al. · 2002 [cited by applicant]
US 7271952B2 · Suzuki et al. · 2007 [cited by applicant]
US 7390463B2 · He et al. · 2008 [cited by applicant]
US 8551710B2 · Bernitz et al. · 2013 [cited by applicant]
US 9371598B2 · Chee · 2016 [cited by applicant]
US 9556473B2 · Bernitz et al. · 2017 [cited by applicant]
US 9593365B2 · Frisen et al. · 2017 [cited by applicant]
US 9598723B2 · Ammann et al. · 2017 [cited by applicant]
US 10059990B2 · Boyden et al. · 2018 [cited by applicant]
US 10114015B2 · Glezer et al. · 2018 [cited by applicant]
US 10138509B2 · Church et al. · 2018 [cited by applicant]
US 10266888B2 · Daugharthy et al. · 2019 [cited by applicant]
US 10323272B1 · Rabbani et al. · 2019 [cited by applicant]
US 10495554B2 · Deisseroth et al. · 2019 [cited by applicant]
US 10774374B2 · Frisen et al. · 2020 [cited by applicant]
US 10841507B2 · Schürf et al. · 2020 [cited by applicant]
US 11155858B2 · Glezer et al. · 2021 [cited by applicant]
US 11434525B2 · Glezer · 2022 [cited by applicant]
US 11486004B2 · Witters et al. · 2022 [cited by applicant]
US 11492662B2 · Glezer · 2022 [cited by examiner]
US 11643679B2 · Glezer · 2023 [cited by examiner]
US 11680288B2 · Glezer · 2023 [cited by applicant]
US 11753678B2 · Glezer · 2023 [cited by applicant]
US 11891656B2 · Glezer et al. · 2024 [cited by applicant]
US 12006534B2 · Glezer · 2024 [cited by applicant]
US 12180542B2 · Glezer et al. · 2024 [cited by applicant]
US 20010053519A1 · Fodor et al. · 2001 [cited by applicant]
US 20020064779A1 · Landegren et al. · 2002 [cited by applicant]
US 20030032024A1 · Lizardi et al. · 2003 [cited by applicant]
US 20030049862A1 · He et al. · 2003 [cited by applicant]
US 20030077580A1 · Catanzariti et al. · 2003 [cited by applicant]
US 20030082556A1 · Kaufman et al. · 2003 [cited by applicant]
US 20030143536A1 · Lizardi · 2003 [cited by applicant]
US 20040137484A1 · Zhang et al. · 2004 [cited by applicant]
US 20050089860A1 · Arita · 2005 [cited by applicant]
US 20050130173A1 · Leamon · 2005 [cited by examiner]
US 20050142556A1 · Hoon et al. · 2005 [cited by applicant]
US 20050208644A1 · Takiguchi et al. · 2005 [cited by applicant]
US 20050287526A1 · Landegren et al. · 2005 [cited by applicant]
US 20050287578A1 · Davis · 2005 [cited by applicant]
US 20060050376A1 · Houston et al. · 2006 [cited by applicant]
US 20060292559A1 · Reddy et al. · 2006 [cited by applicant]
US 20090048119A1 · Krjutskov et al. · 2009 [cited by applicant]
US 20090298718A1 · Denman et al. · 2009 [cited by applicant]
US 20110223585A1 · Gullberg et al. · 2011 [cited by applicant]
US 20120301886A1 · Farrell et al. · 2012 [cited by applicant]
US 20140056811A1 · Jacob et al. · 2014 [cited by applicant]
US 20140057799A1 · Johnson et al. · 2014 [cited by applicant]
US 20140120534A1 · Bernitz et al. · 2014 [cited by applicant]
US 20140170654A1 · Landegren et al. · 2014 [cited by applicant]
US 20140256588A1 · Glezer et al. · 2014 [cited by applicant]
US 20150167092A1 · Kartalov et al. · 2015 [cited by applicant]
US 20150225778A1 · Hindson et al. · 2015 [cited by applicant]
US 20160108392A1 · Stelling · 2016 [cited by applicant]
US 20160116384A1 · Chen et al. · 2016 [cited by applicant]
US 20160145696A1 · Brandon et al. · 2016 [cited by applicant]
US 20160257993A1 · Boyden et al. · 2016 [cited by applicant]
US 20160304952A1 · Boyden et al. · 2016 [cited by applicant]
US 20160369329A1 · Cai et al. · 2016 [cited by applicant]
US 20170067096A1 · Wassie et al. · 2017 [cited by applicant]
US 20170067925A1 · Spence et al. · 2017 [cited by applicant]
US 20170107563A1 · Samusik et al. · 2017 [cited by applicant]
US 20170343539A1 · Epstein et al. · 2017 [cited by applicant]
US 20180187242A1 · Makrigiorgos · 2018 [cited by examiner]
US 20180246076A1 · Qian et al. · 2018 [cited by applicant]
US 20190017106A1 · Frisen et al. · 2019 [cited by applicant]
US 20190032121A1 · Daugharthy et al. · 2019 [cited by applicant]
US 20190055594A1 · Samusik et al. · 2019 [cited by applicant]
US 20190064109A1 · Brown et al. · 2019 [cited by applicant]
US 20190071668A1 · Schmidt et al. · 2019 [cited by applicant]
US 20190113423A1 · Goodman et al. · 2019 [cited by applicant]
US 20190119735A1 · Deisseroth et al. · 2019 [cited by applicant]
US 20190145982A1 · Chee et al. · 2019 [cited by applicant]
US 20190155835A1 · Daugharthy et al. · 2019 [cited by applicant]
US 20190161796A1 · Hauling et al. · 2019 [cited by applicant]
US 20190177718A1 · Church et al. · 2019 [cited by applicant]
US 20190194709A1 · Church et al. · 2019 [cited by applicant]
US 20190241945A1 · Malyshev · 2019 [cited by examiner]
US 20190241950A1 · Daugharthy et al. · 2019 [cited by applicant]
US 20190258777A1 · Bo et al. · 2019 [cited by applicant]
US 20190264279A1 · Kain et al. · 2019 [cited by applicant]
US 20190376123A1 · Bobrow et al. · 2019 [cited by applicant]
US 20190391140A1 · Aghvanyan et al. · 2019 [cited by applicant]
US 20200071751A1 · Daugharthy et al. · 2020 [cited by applicant]
US 20200087707A1 · Engreitz · 2020 [cited by applicant]
US 20200103639A1 · Skinner et al. · 2020 [cited by applicant]
US 20200124601A1 · Fan et al. · 2020 [cited by applicant]
US 20200140944A1 · Belgrader et al. · 2020 [cited by applicant]
US 20200224244A1 · Nilsson · 2020 [cited by examiner]
US 20200224544A1 · Barker · 2020 [cited by examiner]
US 20200271556A1 · Sarkar et al. · 2020 [cited by applicant]
US 20200277663A1 · Ramachandran Iyer et al. · 2020 [cited by applicant]
US 20200277664A1 · Frenz · 2020 [cited by applicant]
US 20200290043A1 · Williamson et al. · 2020 [cited by applicant]
US 20200294439A1 · Mandle et al. · 2020 [cited by applicant]
US 20200362334A1 · Regev et al. · 2020 [cited by applicant]
US 20200393477A1 · Davey et al. · 2020 [cited by applicant]
US 20210017596A1 · Tong et al. · 2021 [cited by applicant]
US 20210039062A1 · Mirkin et al. · 2021 [cited by applicant]
US 20210108195A1 · Bernate et al. · 2021 [cited by applicant]
US 20210164029A1 · Sekedat et al. · 2021 [cited by applicant]
US 20210164039A1 · Wang et al. · 2021 [cited by applicant]
US 20210189481A1 · Glezer et al. · 2021 [cited by applicant]
US 20210198727A1 · Kühnemund et al. · 2021 [cited by applicant]
US 20210222262A1 · Bakaher et al. · 2021 [cited by applicant]
US 20210262018A1 · Bava et al. · 2021 [cited by applicant]
US 20210292834A1 · Daugharthy et al. · 2021 [cited by applicant]
US 20210318530A1 · Deissler · 2021 [cited by applicant]
US 20210333211A1 · Chen et al. · 2021 [cited by applicant]
US 20210363579A1 · Daugharthy · 2021 [cited by applicant]
US 20210382033A1 · Mir · 2021 [cited by applicant]
US 20210388424A1 · Bava · 2021 [cited by applicant]
US 20220042084A1 · Glezer · 2022 [cited by applicant]
US 20220112486A1 · Ramachandran Iyer et al. · 2022 [cited by applicant]
US 20220333174A1 · Glezer et al. · 2022 [cited by applicant]
US 20220403456A1 · Glezer et al. · 2022 [cited by applicant]
US 20220403457A1 · Glezer et al. · 2022 [cited by applicant]
US 20230027467A1 · Fredriksson · 2023 [cited by examiner]
US 20230088043A1 · Kovacs et al. · 2023 [cited by applicant]
US 20230097368A1 · Glezer · 2023 [cited by applicant]
US 20230100215A1 · Glezer et al. · 2023 [cited by applicant]
US 20230203570A1 · Kovacs et al. · 2023 [cited by applicant]
US 20230357828A1 · Glezer · 2023 [cited by applicant]
US 20230366013A1 · Glezer · 2023 [cited by applicant]
US 20230374572A1 · Glezer · 2023 [cited by applicant]
US 20240026428A1 · Glezer et al. · 2024 [cited by applicant]
JP 2005265627A · 2005 [cited by applicant]
JP 5970959B2 · 2016 [cited by applicant]
WO WO2005039389A2 · 2005 [cited by applicant]
WO WO2008042067A2 · 2008 [cited by applicant]
WO WO2013090360A2 · 2013 [cited by applicant]
WO WO2013090360A3 · 2013 [cited by applicant]
WO WO2014030066A2 · 2014 [cited by applicant]
WO WO2014030066A3 · 2014 [cited by applicant]
WO WO2017079382A1 · 2017 [cited by applicant]
WO WO2018091676A1 · 2018 [cited by applicant]
WO WO2019068880A1 · 2019 [cited by applicant]
WO WO2019084062A1 · 2019 [cited by applicant]
WO WO2019199579A1 · 2019 [cited by applicant]
WO WO2019222284A1 · 2019 [cited by applicant]
WO WO2020028194A1 · 2020 [cited by applicant]
WO WO2020076976A1 · 2020 [cited by applicant]
WO WO2020076979A1 · 2020 [cited by applicant]
WO WO2020096687A1 · 2020 [cited by applicant]
WO WO2020099640A1 · 2020 [cited by applicant]
WO WO2020123309A1 · 2020 [cited by applicant]
WO WO2020160044A1 · 2020 [cited by applicant]
WO WO2022032194A1 · 2022 [cited by applicant]
WO WO2022032195A2 · 2022 [cited by applicant]
WO WO2022032195A3 · 2022 [cited by applicant]
WO WO2022235764A1 · 2022 [cited by applicant]
Ambardar et al., High Throughput Sequencing: An Overview of Sequencing Chemistry. Indian J. of Microbiology 56(4) :394 (Year: 2016). [cited by examiner]
Krywkowski et al., Chpt. 14 : Padlock Probes to detect Single Nucleotide Polymorphisms. Methods in Molecular Biology 1649 :209 (Year: 2018). [cited by examiner]
You et al., Design of LNA probes that improve mismatch discrimination. Nucleic Acids Research 34(8) : e60 (Year: 2006). [cited by examiner]
Zhang et al., Amplification of circularizable probes for the detection of target nucleic acids and proteins. Clinical Chemistry Acta 363: 61 (Year: 2006). [cited by examiner]
Wahlestedt et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. PNAS 97(10) : 5633-5638 (Year: 2000). [cited by examiner]
Payne A., MIT Master Thesis Towards Sequencing by synthesis in situ (Year: 2017). [cited by examiner]
Krywkowski et al.Methods in Molecular Biology 1649:209 (Year: 2018). [cited by examiner]
Agrawal, S. et al. (Nov. 15, 2016). “Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy,” [cited by applicant]
Ahern, H. (1995) “Biochemical, reagent kits offer scientists good return on investment,” [cited by applicant]
Alon, S. et al. (2020). “Expansion Sequencing: Spatially Precise In Situ Transcriptomics in Intact Biological Systems,” [cited by applicant]
Arce, S. et al. (2013). “Fast and accurate automated cell boundary determination for fluorescence microscopy,” [cited by applicant]
Banér, J. et al. (April 1, 005). “Analysis of T-cell receptor vβ gene repertoires after immune stimulation and in malignancy by use of padlock probes and microarrays,” [cited by applicant]
Bullinger, L. et al. (Apr. 15, 2004). “Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia,” [cited by applicant]
Carow, B. et al. (2019). “Spatial and temporal localization of immune transcripts defines hallmarks and diversity in the tuberculosis granuloma,” [cited by applicant]
Carpenter, A. E. et al (2006, e-published Oct. 31, 2016). “CellProfiler: image analysis software for identifying and quantifying cell phenotypes,” [cited by applicant]
Catuogno, S. et al. (Apr. 8, 2011). “Recent advance in biosensors for microRNAs detection in cancer,” [cited by applicant]
Chen, F. et al. (Jan. 30, 2015, e-published Jan. 15, 2015). “Optical imaging. Expansion microscopy,” [cited by applicant]
Chen, K. H. et al. (Apr. 24, 2015, e-published Apr. 9, 2015). “RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells,” [cited by applicant]
Chen, X. et al. (Feb. 28, 2018, e-published Nov. 28, 2017). “Efficient in situ barcode sequencing using padlock probe-based BaristaSeq,” [cited by applicant]
Christian, A.T. et al. (Dec. 4, 2001, e-published Nov. 27, 2001). “Detection of DNA point mutations and mRNA expression levels by rolling circle amplification in individual cells,” [cited by applicant]
Costea, P. I. et al. (Mar. 4, 2013). “TagGD: fast and accurate software for DNA Tag generation and demultiplexing,” [cited by applicant]
Daigeler, A. et al. (Jul. 6, 2006). “Clinicopathological findings in a case series of extrathoracic solitary fibrous tumors of soft tissues,” [cited by applicant]
Denkert, C. et al. (Nov. 1, 2015, e-published Aug. 14, 2015). “Strategies for developing Ki67 as a useful biomarker in breast cancer,” [cited by applicant]
Edelman, M. J. et al. (May 1997, e-published Feb. 28, 2002). “The utility of follow-up testing after curative cancer therapy: a critical review and economic analysis,” [cited by applicant]
El-Sagheer, A. H. et al. (Aug. 21, 2012, e-published Mar. 22, 2012).“Click nucleic acid ligation: applications in biology and nanotechnology,” [cited by applicant]
Extended European Search Report mailed Mar. 18, 2024, for EP Application No. 21852670.5, 13 pages. [cited by applicant]
Fijnvandraat, A. C. et al. (Sep. 1, 2002, e-published Sep. 10, 2002). “Nonradioactive in situ detection of mRNA in ES cell-derived cardiomyocytes and in the developing heart,” [cited by applicant]
Frank, D. N. (Oct. 29, 2009). “BARCRAWL and BARTAB: software tools for the design and implementation of barcoded primers for highly multiplexed DNA sequencing,” [cited by applicant]
Fredriksson, S. et al. (Apr. 2007, e-published Mar. 18, 2007). “Multiplexed protein detection by proximity ligation for cancer biomarker validation,” [cited by applicant]
Fredriksson, S. et al. (May 1, 2002). “Protein detection using proximity-dependent DNA ligation assays,” [cited by applicant]
Gao, H. et al. (Dec. 2019, e-published Oct. 17, 2019). “Rolling circle amplification for single cell analysis and in situ sequencing,” [cited by applicant]
Garmendia, C. et al. (Feb. 1992). “The bacteriophage phi 29 DNA polymerase, a proofreading enzyme,” [cited by applicant]
Gelali, E. et al. (Apr. 9, 2019). “iFISH is a publically available resource enabling versatile DNA FISH to study genome architecture,” [cited by applicant]
Gore, A. et al. (Mar. 3, 2011). “Somatic coding mutations in human induced pluripotent stem cells,” [cited by applicant]
Gullberg, M. et al. (May 21, 2004). “Cytokine detection by antibody-based proximity ligation,” [cited by applicant]
Guo, J. et al. (Jul. 8, 2008, e-published Jun. 30, 2008). “Four-color DNA sequencing with 3′- O-modified nucleotide reversible terminators and chemically cleavable fluorescent dideoxynucleotides,” [cited by applicant]
Gyllborg, D. et al. (Nov. 4, 2020). “Hybridization-based in situ sequencing (HybISS) for spatially resolved transcriptomics in human and mouse brain tissue,” [cited by applicant]
Hagai, T. et al. (Nov. 2018, e-published Oct. 24, 2018). “Gene expression variability across cells and species shapes innate immunity,” [cited by applicant]
Hamaday, M. et al. (Mar. 2008) “Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex,” [cited by applicant]
Hamilton, N. (2009) “Quantification and its applications in fluorescent microscopy imaging.” [cited by applicant]
Hardenbol, P. et al. (2003) “Multiplexed genotyping with sequence-tagged molecular inversion probes.” [cited by applicant]
Heintzmann, R. et al. (Dec. 13, 2017, e-published Nov. 10, 2017). “Super-Resolution Structured Illumination Microscopy,” [cited by applicant]
Hu, Y. et al. (2014) “Sensitive quantification of messenger RNA with a real-time ligase chain reaction by using a ribonucleotide-modified DNA probe.” [cited by applicant]
International Search Report and Written Opinion mailed on Nov. 23, 2021, for PCT Application No. PCT/US2021/045104, filed Aug. 6, 2021, 15 pages. [cited by applicant]
International Search Report & Written Opinion mailed on Jan. 31, 2022, for PCT Application No. PCT/US2021/045105, filed Aug. 6, 2022, 18 pages. [cited by applicant]
International Search Report & Written Opinion mailed on Sep. 19, 2022, for PCT Application No. PCT/US2022/027630, filed May 4, 2022, 14 pages. [cited by applicant]
Jeong, S. et al. (Apr. 2020, e-published Jan. 30, 2020). “Current immunoassay methods and their applications to clinically used biomarkers of breast cancer,” [cited by applicant]
Kappler, K. et al. (Aug. 2020, e-published Aug. 5, 2020). “Emergence and significance of carbohydrate-specific antibodies,” [cited by applicant]
Ke, R. et al. (Sep. 2013, e-published Jul. 14, 2013) “In situ sequencing for RNA analysis in preserved tissue and cells.” [cited by applicant]
Klein A.M., et al. (Jul. 25, 2017). “InDrops and Drop-seq technologies for single-cell sequencing,” [cited by applicant]
Kobori, T. et al. (2014) “Expanding possibilities of rolling circle amplification as a biosensing platform,” [cited by applicant]
Kohman, R. E. et al. (Apr. 28, 2020). “Fluorescent in situ sequencing of DNA barcoded antibodies,” [cited by applicant]
Lareau, C. A., et al. (Feb. 13, 2020). “Inference and effects of barcode multiplets in droplet-based single-cell assays,” [cited by applicant]
Larsson, C. et al., (May 2010, e-published Apr. 11, 2010). “In situ detection and genotyping of individual mRNA molecules,” [cited by applicant]
Lee, J. H. et al. (e-published Feb. 12, 2015). “Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues,” [cited by applicant]
Lee, J. H. et al. (Feb. 27, 2014, e-published Feb. 20, 2014). “Highly multiplexed subcellular RNA sequencing in situ,” [cited by applicant]
Li, J. B. et al. (Sep. 2009, e-published Jun. 12, 2009). Multiplex padlock targeted sequencing reveals human hypermutable CpG variations, [cited by applicant]
Li, J. B. et al. (May 29, 2009). “Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing,” [cited by applicant]
Li, N. et al. (May 21, 2009) “Stand-alone rolling circle amplification combined with capillary electrophoresis for specific detection of small RNA.” [cited by applicant]
Lubeck, E. et al. (Jul. 2012, e-published Jun. 3, 2012). “Single-cell systems biology by super-resolution imaging and combinatorial labeling,” [cited by applicant]
Lubeck, E. et al. (Apr. 2014, e-published Mar. 28, 2014). “Single-cell in situ RNA profiling by sequential hybridization,” [cited by applicant]
Manuguerra I. et al. (May 1, 2018). “Gene assembly via one-pot chemical ligation of DNA promoted by DNA nanostructures,” [cited by applicant]
Mignardi, M. et al. (Apr. 28, 2014). “Fourth-generation sequencing in the cell and the clinic,” [cited by applicant]
Mitra, R.D. et al. (2003) “Fluorescent in situ sequencing on polymerase colonies.” [cited by applicant]
Mohammadi-Kambs, M. et al. (2017) “Hamming distance as a concept in DNA molecular recognition.” [cited by applicant]
Nilsson, M. et al. (Sep. 30, 1994). “Padlock probes: circularizing oligonucleotides for localized DNA detection,” [cited by applicant]
Nitta, H. et al. (Aug. 2013, e-published Nov. 15, 2015). “New methods for ALK status diagnosis in non-small-Cell lung Cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-In situ hybrid… [cited by applicant]
Odeh, F., et al. (Dec. 18, 2019). “Aptamers Chemistry: Chemical Modifications and Conjugation Strategies,” [cited by applicant]
Ouladan, S. et al. (Jun. 2015, e-published Apr. 20, 2015). “Differential diagnosis of solitary fibrous tumors: A study of 454 soft tissue tumors indicating the diagnostic value of nuclear STAT6 relocation and ALDH1 expr… [cited by applicant]
Park, M. S. et al. (May 11, 2013). “The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis,” [cited by applicant]
Patel, A.P. et al. (Jun. 20, 2014, e-published Jun. 12, 2014). “Single-cell RNA—seq highlights intratumoral heterogeneity in primary glioblastoma,” [cited by applicant]
Pearson, A. et al. (Aug. 2016, e-published May 13, 2016). “High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial,” [cited by applicant]
Peerzade, S.A. et al. (May 8, 2020). “Ultrabright Fluorescent Silica Nanoparticles for Multiplexed Detection,” [cited by applicant]
Peters, J.M. et al. (Jan. 2011). “Multiparameter flow cytometry in the diagnosis and management of acute leukemia,” [cited by applicant]
Porreca, G. J. et al. (Nov. 2007, e-published Oct. 14, 2007). “Multiplex amplification of large sets of human exons,” [cited by applicant]
Rouhanifard, S. H., et al. (2018) “Exponential fluorescent amplification of individual RNAs using clampFISH probes.” [cited by applicant]
Sansone, A. (Jun. 2019). “Spatial transcriptomics levels up,” [cited by applicant]
Sapoznik, E. et al. (Nov. 12, 2020). “A versatile oblique plane microscope for large-scale and high-resolution imaging of subcellular dynamics,” [cited by applicant]
Schallmeiner, E. et al. (Feb. 1, 2007, e-published Dec. 17, 2006). “Sensitive protein detection via triple-binder proximity ligation assays,” [cited by applicant]
Schlachter, S. et al. (2009). “A method to unmix multiple fluorophores in microscopy images with minimal a priori information,” [cited by applicant]
Shirakawa, H. et al. (Mar. 2004). “Blind spectral decomposition of single-cell fluorescence by parallel factor analysis,” [cited by applicant]
Stratagene Catalog, The (1988). p. 39. [cited by applicant]
Strell, C. et al. (Apr. 2019, e-published Mar. 14, 2019). “Placing RNA in context and space—methods for spatially resolved transcriptomics,” [cited by applicant]
Suzuki, A. et al. (Dec. 20, 2019). “Characterization of cancer omics and drug perturbations in panels of lung cancer cells,” [cited by applicant]
Takahashi, H. et al. (2018) “RNase H-assisted RNA-primed rolling circle amplification for targeted RNA sequence detection.” [cited by applicant]
Tang, S. et al. (Aug. 2, 2016). “Suppression of rolling circle amplification by nucleotide analogs in circular template for three DNA polymerases,” [cited by applicant]
Turczyk, B. M. et al. (Jul. 2020). “Spatial sequencing: a perspective,” [cited by applicant]
Vickovic, S. et al. (Oct. 2019, e-published Sep. 9, 2019). “High-definition spatial transcriptomics for in situ tissue profiling,” [cited by applicant]
Wang, G. et al. (Mar. 19, 2018). “Multiplexed imaging of high-density libraries of RNAs with MERFISH and expansion microscopy,” [cited by applicant]
Wang X. et al. (Jul. 27, 2018, e-published Jun. 21, 2018). “Three-dimensional intact-tissue sequencing of single-cell transcriptional states,” [cited by applicant]
Wassie, A. T. et al. (e-published Dec. 20, 2018). “Expansion microscopy: principles and uses in biological research,” [cited by applicant]
Weibrecht, I. et al. (Jan. 2013) “In situ detection of individual mRNA molecules and protein complexes or post-translational modifications using padlock probes combined with the in situ proximity ligation assay.” [cited by applicant]
Wilson, C.S. et al. (Jul. 15, 2006, e-published Apr. 4, 2006). “Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction,” [cited by applicant]
Xu, Q. et al. (2009) “Design of 240,000 orthogonal 25mer DNA barcode probes.” [cited by applicant]
York, A.G. et al. (Nov. 2013, e-published Oct. 6, 2013). “Instant super-resolution imaging in live cells and embryos via analog image processing,” [cited by applicant]
Zhang, K. et al. (Aug. 2009, e-published Jul. 20, 2009). “Digital RNA allelotyping reveals tissue-specific and allele-specific gene expression in human,” [cited by applicant]
Zheng, G. X. et al. (Jan. 16, 2017). “Massively parallel digital transcriptional profiling of single cells,” [cited by applicant]
Ambardar, S. et al. (Dec. 2016, e-published Jul. 9, 2016). “High throughput sequencing: an overview of sequencing chemistry,” [cited by applicant]
Borkamo, E. D. et al. (Dec. 1, 2009, e-published Nov. 19, 2009). “cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy,” [cited by applicant]
Conze, T. et al. (Jul. 2009, e-published Feb. 19, 2009). “Analysis of genes, transcripts, and proteins via DNA ligation,” [cited by applicant]
Frances-Soriano, L. et al. (Jan. 26, 2021, e-published Dec. 28, 2020). “In Situ rolling circle amplification Forster resonance energy transfer (RCA-FRET) for washing-free real-time single-protein imaging,” [cited by applicant]
Krzywkowski, T. et al. (Oct. 2018). “Chimeric padlock and iLock probes for increased efficiency of targeted RNA detection,” [cited by applicant]
Roussis, I. M. et al. (Mar. 3, 2017). “RNA whole-mount in situ hybridization proximity ligation assay (rISH-PLA), an assay for detecting RNA-protein complexes in intact cells,” [cited by applicant]
Söderberg, O. et al. (Dec. 2006, e-published Oct. 29, 2006). “Direct observation of individual endogenous protein complexes in situ by proximity ligation,” [cited by applicant]
You, Y. et al. (Apr. 1, 2006, e-published Jan. 1, 2006). “Design of LNA probes that improve mismatch discrimination,” [cited by applicant]
Zhang, D. et al. (Jan. 2006, e-published Aug. 24, 2005). “Amplification of circularizable probes for the detection of target nucleic acids and proteins,” [cited by applicant]
Konry, T. et al. (Feb. 7, 2011, e-published Dec. 27, 2010). “Ultrasensitive detection of low-abundance surface-marker protein using isothermal rolling circle amplification in a microfluidic nanoliter platform,” [cited by applicant]
Payne, A. C. (Jun. 2017, e-published Jul. 31, 2017). “Towards sequencing by synthesis in situ. Doctoral Dissertation.” [cited by applicant]